Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023
   PCE(x) -970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is -970.75 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹112.4 Cr -1.5% -0.5% -11% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,901.4 Cr -0% 1.9% 36.9% Stock Analytics
KIRI INDUSTRIES ₹3,233.2 Cr 2% -0.4% 72.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,005.5 Cr 1.7% -4.1% -7.4% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,217.7 Cr 5.1% 22.9% 57.1% Stock Analytics
BODAL CHEMICALS ₹968.1 Cr -0% 13.4% 0.4% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-1.5%

-0.5%

-11%

SENSEX

-0.1%

1%

1.8%


You may also like the below Video Courses